Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PDUFA
Biotech
FDA proposes higher fees for ph. 1 trials conducted outside of US
The proposal is designed to incentivize U.S. drug development by tacking on higher fees for those not running phase 1 trials in the country.
Gabrielle Masson
Dec 3, 2025 5:19pm
Denali's Hunter syndrome drug latest to be hit by FDA delay
Oct 14, 2025 8:09am
Regenxbio's Hunter gene therapy latest to face FDA delay
Aug 19, 2025 10:30am
FDA delays Omeros' 2nd attempt at transplant drug’s approval
Aug 15, 2025 5:55am
FDA rejects Capricor’s DMD cell therapy, asks for more data
Jul 11, 2025 9:18am
FDA 'on track' to meet all PDUFA dates, Marty Makary says
Jun 18, 2025 4:00am